SEC Filing Summary: Landec Corporation (8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Landec Corporation (not Lifecore Biomedical, Inc.) on May 7, 2019, covering events occurring on May 6, 2019. The registrant is incorporated in Delaware and trades on the NASDAQ Global Select Market under the symbol LNDC.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a corporate governance filing and does not contain financial performance data.
Material Changes
Effective May 6, 2019, the Board of Directors adopted an amendment to Section 2.5(a) of the Company's By-Laws. This amendment extends the deadline for submitting stockholder nominations for the Board and business proposals for the 2019 Annual Meeting of Stockholders to 5:00 p.m. PT on May 29, 2019.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is limited to the procedural amendment of the By-Laws.
Key Facts for Investor Verification
- Verify the correct registrant name is Landec Corporation (LNDC), as the input metadata referenced Lifecore Biomedical, Inc.
- Confirm the new deadline for stockholder proposals and director nominations is May 29, 2019, at 5:00 p.m. PT.
- Note that this filing does not impact the company's financial statements or operational results.